These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9933846)

  • 21. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
    Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
    Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.
    Kaelin A; Casez JP; Jaeger P
    Urol Res; 2004 Feb; 32(1):61-8. PubMed ID: 14628106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxalate metabolism after intestinal bypass operations.
    Nordenvall B; Backman L; Larsson L
    Scand J Gastroenterol; 1981 Apr; 16(3):395-9. PubMed ID: 16435482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Effect of calcium and magnesium.
    Barilla DE; Notz C; Kennedy D; Pak CY
    Am J Med; 1978 Apr; 64(4):579-85. PubMed ID: 645724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [24-hour urinary oxalate excretion in healthy children and in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Wawrzyszuk M; Zajaczkowska M
    Pol Merkur Lekarski; 2008; 24 Suppl 4():76-9. PubMed ID: 18924510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C; Campieri M; Bertuzzi V; Swennen E; Matteuzzi D; Stefoni S; Pirovano F; Centi C; Ulisse S; Famularo G; De Simone C
    Kidney Int; 2001 Sep; 60(3):1097-105. PubMed ID: 11532105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oxalate: a poorly soluble organic waste with consequences].
    Lu Y; Bonny O
    Praxis (Bern 1994); 2015 Mar; 104(7):353-9. PubMed ID: 25804778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a probiotic to decrease enteric hyperoxaluria.
    Lieske JC; Goldfarb DS; De Simone C; Regnier C
    Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.
    Lieske JC; Tremaine WJ; De Simone C; O'Connor HM; Li X; Bergstralh EJ; Goldfarb DS
    Kidney Int; 2010 Dec; 78(11):1178-85. PubMed ID: 20736987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excretion of urinary calcium and oxalate on three diets in patients with urolithiasis.
    Juuti M; Alhava EM
    Ann Clin Res; 1980 Dec; 12(6):320-5. PubMed ID: 7235608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperoxaluria in idiopathic calcium oxalate nephrolithiasis.
    Yendt ER
    Md Med J; 1988 Nov; 37(11):857-60. PubMed ID: 3185157
    [No Abstract]   [Full Text] [Related]  

  • 34. End Point Considerations for Clinical Trials in Enteric Hyperoxaluria.
    Langman CB; Assimos D; Blank M; Calle J; Grauer A; Kausz A; Milliner D; Nazzal L; Smith K; Tasian G; Thompson A; Wood KD; Worcester E; Yang S; Malley MA; Knauf F; Lieske JC;
    Clin J Am Soc Nephrol; 2023 Dec; 18(12):1637-1644. PubMed ID: 37342976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Randomized Evaluation of Idiopathic Hyperoxaluria Treatments.
    Gupta M; Gallante B; Bamberger JN; Khusid JA; Parkhomenko E; Chandhoke R; Capodice J; Atallah W
    J Endourol; 2021 Dec; 35(12):1844-1851. PubMed ID: 34254834
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G; Haton D; Wolf JP; Henriet MT; Nguyen NU; Mougin C; Saint-Hillier Y; Combes M; Berthelay S
    Nephrologie; 1984; 5(5):189-91. PubMed ID: 6531054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers.
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Am J Nephrol; 1985; 5(1):40-4. PubMed ID: 3970077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of dietary oxalate and calcium reduces urinary oxalate in hyperoxaluric patients with kidney stones.
    Massey LK; Sutton RA
    J Am Diet Assoc; 1993 Nov; 93(11):1305-7. PubMed ID: 8227883
    [No Abstract]   [Full Text] [Related]  

  • 39. Enteric hyperoxaluria: dependence on small intestinal resection, colectomy, and steatorrhoea in chronic inflammatory bowel disease.
    Hylander E; Jarnum S; Jensen HJ; Thale M
    Scand J Gastroenterol; 1978; 13(5):577-88. PubMed ID: 705253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial hyperoxaluria and intestinal oxalate absorption in idiopathic renal stone disease.
    Schwille PO; Hanisch E; Scholz D
    J Urol; 1984 Oct; 132(4):650-5. PubMed ID: 6471206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.